El-Hibri Fuad Blog

Archive for the ‘Board of directors’ Category

by Nick Rees on December 8, 2009 Fuad El-Hibri The Office of the Biomedical Advanced Research and Development Authority has advised Emergent BioSolutions that while BARDA’s Request for Proposal has been canceled, Emergent is encouraged to submit a proposal for the office’s Broad Agency Announcement. BARDA canceled the RFP for the procurement for rPA vaccines [...]

CEO & Chairman, 10% Owner of Emergent BioSolutions Inc. (EBS) Fuad El-hibri sells 15,000 shares of EBS on 08/11/2009 at an average price of $16.78 a share. EMERGENT BIOSULUTIONS INC. is a leading biopharmaceutical company dedicated to one simple mission – to protect life. EBS develops manufactures and commercializes vaccines and therapeutics that assist the [...]

Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript

Posted by: fuadelhibri on: August 17, 2009

Emergent BioSolutions Inc., (EBS) Q2 2009 Earnings Call August 6, 2009 5:00 pm ET Executives Robert G. Burrows – Vice President, Investor Relations Fuad El-Hibri – Chairman of the Board, Chief Executive Officer R. Don Elsey – Chief Financial Officer Daniel J. Abdun-Nabi – President, Chief Operating Officer W. James Jackson, Ph.D. – Senior Vice [...]

Fuad El-Hibri on Vox

Posted by: fuadelhibri on: August 17, 2009

Mr. Fuad El-Hibri is the Chairman and Chief Executive Officer of Emergent BioSolutions Inc. (Emergent) family, health, polo, music, telecommunications, telecom, science, technology, banking, mergers, acquisitions, management, academia

Fuad El-Hibri is a Washington-Area Success Story

Posted by: fuadelhibri on: August 17, 2009

Fuad El-Hibri has served as chief executive officer and as chairman of our board of directors since June 2004 and as president since March 2006. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of our corporate [...]


Follow

Get every new post delivered to your Inbox.